Related Experiment Video

Updated: Aug 15, 2026

Direct Observation of Phagocytosis and NET-formation by Neutrophils in Infected Lungs using 2-photon Microscopy
08:50

Direct Observation of Phagocytosis and NET-formation by Neutrophils in Infected Lungs using 2-photon Microscopy

Published on: June 2, 2011

[Pneumothorax as a complication of chronic necrotizing pulmonary aspergillosis]

H C J van Klink1, J Stolk

  • 1Leids Universitair Medisch Centrum, afd. Longziekten, Postbus 9600, 2300 RC, Leiden. h.c.j.van-klink@lumc.nl

Nederlands Tijdschrift Voor Geneeskunde
|April 1, 2005
PubMed

Insights

A patient with chronic obstructive pulmonary disease (COPD) developed a pneumothorax due to chronic necrotizing pulmonary aspergillosis. This fungal infection led to respiratory failure and death, highlighting the severe complications of invasive aspergillosis in immunocompromised patients.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Mycology

Background:

  • Chronic obstructive pulmonary disease (COPD) is a progressive lung disease.
  • Recurrent exacerbations of COPD often require treatment with corticosteroids like prednisone.
  • Prednisone can increase the risk of opportunistic infections.

Observation:

  • A 65-year-old male COPD patient presented with pneumothorax.
  • The pneumothorax was identified as a complication of chronic necrotizing pulmonary aspergillosis.
  • The patient had a history of frequent prednisone treatment for COPD exacerbations.

Findings:

  • Chronic necrotizing pulmonary aspergillosis can lead to severe respiratory complications.
  • Invasive fungal infections pose a significant risk in patients with compromised lung function and corticosteroid use.
  • Despite aggressive treatment, the patient succumbed to respiratory insufficiency.

Implications:

  • This case underscores the importance of considering invasive fungal infections in COPD patients with recurrent exacerbations and corticosteroid therapy.
  • Early diagnosis and management of pulmonary aspergillosis are crucial for improving patient outcomes.
  • Pulmonary aspergillosis can be a fatal complication, particularly in patients with underlying severe lung disease.

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...